BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
for
Clinical Stage III Cutaneous Melanoma AJCC v8,
Location: Springfield MA, Saint Johnsbury VT, Lebanon NH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05136196
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
for
Recurrent Head and Neck Squamous Cell Carcinoma,
Location: Boston MA, Waterford CT, New Haven CT, Stony Brook NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT04671667
Phase2, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
for
Crohn's Disease
Location: Kentville, Boston MA, Providence RI, Levis,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 16 - 70+
Code: NCT06430801
Phase3, Recruiting
Active & Responsive
Restoration of Hand Function in Cervical SCI
for
Spinal Cord Injury Cervical
Location: Cleveland OH
Sponsor: MetroHealth Medical Center
Sex: All
Age: 18+
Code: NCT06611748
Recruiting
Active & Responsive
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
for
Myasthenia Gravis, Generalized Myasthenia Gravis
Location: Philadelphia PA, Miami FL, Indianapolis IN, Columbia MO,
Sponsor: Kyverna Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06193889
Phase2, Phase3, Recruiting
Active & Responsive
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Boston MA, Saint Johnsbury VT, Lebanon NH, Commack NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06589804
Phase3, Recruiting
Active & Responsive
Pain Outcomes Associated With Exogenous Hormone Therapy in Adults
for
Pain, Gender Minority Individuals
Location: Kansas City KS
Sponsor: University of Kansas Medical Center
Sex: All
Age: 18 - 50
Code: NCT06939257
Recruiting
Active & Responsive
PCS in Severe Treatment Resistant Depression
for
Treatment Resistant Depression
Location: Minneapolis MN
Sponsor: University of Minnesota
Sex: All
Age: 22 - 70
Code: NCT04124341
Recruiting
Active & Responsive
Cardiometabolic Risk Effects of Short-term Cessation of Neurostimulation Therapy
for
Obstructive Sleep Apnea, Obstructive Sleep Apnea of Adult
Location: New York NY
Sponsor: Columbia University
Sex: All
Age: 18+
Code: NCT06720545
Recruiting
Active & Responsive
Positive Processes and Transition to Health - Single-Session (PATH-SS)
for
PTSD, Depression
Location: Cleveland OH
Sponsor: Case Western Reserve University
Sex: All
Age: 18 - 65
Code: NCT06900712
Recruiting
Active & Responsive
Characterizing Synaptic Density in Treatment Resistant Depression
for
Treatment Resistant Depression,
Location: Toronto
Sponsor: Unity Health Toronto
Sex: All
Age: 25 - 65
Code: NCT03537794
Recruiting
Active & Responsive
Brain/Craving Response to Smoking Cues After Oral Nicotine Pouch Use